GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oncopeptides ONCO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.82

+4.60%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 71.1m

FY2016FY2025

Net income

−SEK 249.6m

FY2016FY2025

Free cash flow

−SEK 222.9m

FY2016FY2025

Shareholders' equity

−SEK 58.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 71.1mSEK 31.6mSEK 35.2mSEK 8.4mSEK 118.3mSEK 19.4m————
Research and developmentSEK 99.8mSEK 121.2mSEK 106.9mSEK 217.7mSEK 679.9mSEK 866.2mSEK 548.3mSEK 322.1mSEK 197.8mSEK 89.7m
Operating income−SEK 228.9m−SEK 283.5m−SEK 253.4m−SEK 349.4m−SEK 1.42bn−SEK 1.59bn−SEK 739.4m−SEK 420.1m−SEK 247.6m−SEK 114.5m
Net income−SEK 249.6m−SEK 284.6m−SEK 249.1m−SEK 338.0m−SEK 1.43bn−SEK 1.59bn−SEK 740.7m−SEK 419.4m−SEK 247.6m−SEK 114.4m
Diluted earnings per share-0.96-1.33-2.76-3.74-17.77-23.75-13.78-9.53-6.24-2.95

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 134.8mSEK 244.2mSEK 238.4mSEK 385.3mSEK 439.4mSEK 946.8mSEK 993.5mSEK 444.5mSEK 479.8mSEK 55.6m
Cash and short-term investmentsSEK 82.3mSEK 178.5mSEK 173.4mSEK 344.5mSEK 364.3mSEK 852.5mSEK 926.2mSEK 375.6mSEK 404.1mSEK 40.3m
Total liabilitiesSEK 193.7mSEK 189.9mSEK 181.6mSEK 91.0mSEK 228.5mSEK 369.9mSEK 196.5mSEK 128.7mSEK 61.8mSEK 29.3m
DebtSEK 139.4mSEK 141.7mSEK 126.2mSEK 9.5mSEK 14.2mSEK 19.4mSEK 6.7m———
Shareholders' equity−SEK 58.9mSEK 54.3mSEK 56.8mSEK 294.3mSEK 210.9mSEK 576.9mSEK 797.0mSEK 315.8mSEK 418.0mSEK 26.3m
Shares outstanding261m214m90m90m81m67m54m44m40m39m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 222.9m−SEK 260.6m−SEK 279.5m−SEK 420.5m−SEK 1.52bn−SEK 1.30bn−SEK 690.6m−SEK 333.7m−SEK 271.5m−SEK 104.3m
Capital spending—−SEK 357,000−SEK 116,000−SEK 2.5m−SEK 339,000−SEK 17.2m−SEK 2.6m−SEK 369,000−SEK 1.5m−SEK 1.1m
Free cash flow−SEK 222.9m−SEK 260.9m−SEK 279.6m−SEK 423.0m−SEK 1.52bn−SEK 1.31bn−SEK 693.2m−SEK 334.1m−SEK 273.0m−SEK 105.4m
Dividends paid———−SEK 43.2m−SEK 82.5m−SEK 85.2m−SEK 76.6m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 31.1mSEK 25.4mSEK 18.6mSEK 20.2mSEK 19.2mSEK 13.3mSEK 9.9mSEK 8.5m
Operating income−SEK 51.0m−SEK 40.7m−SEK 62.4m−SEK 47.1m−SEK 56.9m−SEK 60.5m−SEK 83.3m−SEK 61.3m
Net income−SEK 54.7m−SEK 32.2m−SEK 65.2m−SEK 60.9m−SEK 62.8m−SEK 60.7m−SEK 83.4m−SEK 60.2m
Diluted earnings per share-0.14-0.08-0.25-0.23-0.24-0.23-0.39-0.28
Cash from operations−SEK 42.0m−SEK 45.0m−SEK 66.0m−SEK 33.0m−SEK 54.0m−SEK 68.0m−SEK 71.0m−SEK 130.0m
Total assetsSEK 222.0mSEK 271.9mSEK 134.8mSEK 211.3mSEK 136.4mSEK 173.4mSEK 244.2mSEK 319.2m
Cash and short-term investmentsSEK 157.6mSEK 205.2mSEK 82.3mSEK 147.9mSEK 70.1mSEK 107.2mSEK 178.5mSEK 250.0m
DebtSEK 135.2mSEK 130.8mSEK 126.7mSEK 126.2mSEK 124.2mSEK 118.4mSEK 129.2mSEK 117.2m
Shareholders' equitySEK 24.9mSEK 76.8m−SEK 58.9mSEK 6.5m−SEK 66.9m−SEK 5.8mSEK 54.3mSEK 135.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue104.2%29.7%—
Operating income-13.1%-32.1%15.7%
Net income-9.6%-31.0%16.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-498.6%-762.1%-1453.2%—
Net margin-519.8%-766.2%-1460.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-3.1-0.7-1.1-1.3-0.1-0.6-0.8-1.2-1.1
Price to sales10.96.57.952.80.849.9———

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.